233 related articles for article (PubMed ID: 25751242)
1. Genetic Modifiers in β-Thalassemia Intermedia: A Study on 102 Iraqi Arab Patients.
Al-Allawi NA; Puehringer H; Raheem RA; Oberkanins C
Genet Test Mol Biomarkers; 2015 May; 19(5):242-7. PubMed ID: 25751242
[TBL] [Abstract][Full Text] [Related]
2. Molecular Basis of β-Thalassemia Intermedia in Erbil Province of Iraqi Kurdistan.
Shamoon RP; Al-Allawi NA; Cappellini MD; Di Pierro E; Brancaleoni V; Granata F
Hemoglobin; 2015; 39(3):178-83. PubMed ID: 25902180
[TBL] [Abstract][Full Text] [Related]
3. A Population-Oriented Genetic Scoring System to Predict Phenotype: A Pathway to Personalized Medicine in Iraqis With β-Thalassemia.
Al-Allawi N; Atroshi SD; Sadullah RK; Eissa AA; Kriegshäuser G; Al-Zebari S; Qadir S; Khalil D; Oberkanins C
Hemoglobin; 2024 Mar; 48(2):94-100. PubMed ID: 38390736
[TBL] [Abstract][Full Text] [Related]
4. The XmnI (G)gamma polymorphism influences hemoglobin F synthesis contrary to BCL11A and HBS1L-MYB SNPs in a cohort of 57 beta-thalassemia intermedia patients.
Nguyen TK; Joly P; Bardel C; Moulsma M; Bonello-Palot N; Francina A
Blood Cells Mol Dis; 2010 Aug; 45(2):124-7. PubMed ID: 20472475
[TBL] [Abstract][Full Text] [Related]
5. Genetic Modifiers of Sickle Cell Disease: A Genotype-Phenotype Relationship Study in a Cohort of 82 Children on Mayotte Island.
Muszlak M; Pissard S; Badens C; Chamouine A; Maillard O; Thuret I
Hemoglobin; 2015; 39(3):156-61. PubMed ID: 25806420
[TBL] [Abstract][Full Text] [Related]
6. Variability of hemoglobin F expression in hemoglobin EE disease: hematological and molecular analysis.
Pakdee N; Yamsri S; Fucharoen G; Sanchaisuriya K; Pissard S; Fucharoen S
Blood Cells Mol Dis; 2014; 53(1-2):11-5. PubMed ID: 24581976
[TBL] [Abstract][Full Text] [Related]
7. The association of HBG2, BCL11A, and HMIP polymorphisms with fetal hemoglobin and clinical phenotype in Iraqi Kurds with sickle cell disease.
Al-Allawi N; Qadir SMA; Puehringer H; Chui DHK; Farrell JJ; Oberkanins C
Int J Lab Hematol; 2019 Feb; 41(1):87-93. PubMed ID: 30216683
[TBL] [Abstract][Full Text] [Related]
8. Modifying effect of XmnI, BCL11A, and HBS1L-MYB on clinical appearances: A study on β-thalassemia and hemoglobin E/β-thalassemia patients in Indonesia.
Rujito L; Basalamah M; Siswandari W; Setyono J; Wulandari G; Mulatsih S; Sofro AS; Sadewa AH; Sutaryo S
Hematol Oncol Stem Cell Ther; 2016 Jun; 9(2):55-63. PubMed ID: 27009595
[TBL] [Abstract][Full Text] [Related]
9. Polymorphic variations influencing fetal hemoglobin levels: association study in beta-thalassemia carriers and in normal individuals of Portuguese origin.
Pereira C; Relvas L; Bento C; Abade A; Ribeiro ML; Manco L
Blood Cells Mol Dis; 2015 Apr; 54(4):315-20. PubMed ID: 25842369
[TBL] [Abstract][Full Text] [Related]
10. Molecular mechanisms underlying thalassemia intermedia in Iran.
Neishabury M; Azarkeivan A; Oberkanins C; Esteghamat F; Amirizadeh N; Najmabadi H
Genet Test; 2008 Dec; 12(4):549-56. PubMed ID: 18939939
[TBL] [Abstract][Full Text] [Related]
11. Multi-Locus Models to Address Hb F Variability in Portuguese β-Thalassemia Carriers.
Manco L; Bento C; Relvas L; Cunha E; Pereira J; Moreira V; Alvarez M; Maia T; Ribeiro ML
Hemoglobin; 2020 Mar; 44(2):113-117. PubMed ID: 32319326
[TBL] [Abstract][Full Text] [Related]
12. Sickle cell disease in the Kurdish population of northern Iraq.
Al-Allawi NA; Jalal SD; Nerwey FF; Al-Sayan GO; Al-Zebari SS; Alshingaly AA; Markous RD; Jubrael JM; Hamamy H
Hemoglobin; 2012; 36(4):333-42. PubMed ID: 22686351
[TBL] [Abstract][Full Text] [Related]
13. The correlation of α-globin gene mutations and the XmnI polymorphism with clinical severity of Hb E/β-thalassemia.
Charoenkwan P; Teerachaimahit P; Sanguansermsri T
Hemoglobin; 2014; 38(5):335-8. PubMed ID: 25238043
[TBL] [Abstract][Full Text] [Related]
14. Multicenter study of the molecular basis of thalassemia intermedia in different ethnic populations.
Verma IC; Kleanthous M; Saxena R; Fucharoen S; Winichagoon P; Raizuddin S; Khan SN; Akbari MT; Izadyar M; Kotea N; Old JM; Ioannou PA; Khan B
Hemoglobin; 2007; 31(4):439-52. PubMed ID: 17994378
[TBL] [Abstract][Full Text] [Related]
15. [Genotype of thalassemia genes and the polymorphism of β- globin gene in Cantonese].
Liu L; Jiang WY; Xu SY; Chen J; Chen LM; Tian QH; Wang JC
Zhonghua Xue Ye Xue Za Zhi; 2013 Jul; 34(7):595-9. PubMed ID: 23906453
[TBL] [Abstract][Full Text] [Related]
16. The association between four SNPs (rs7482144, rs4671393, rs28384513 and rs4895441) and fetal hemoglobin levels in Chinese Zhuang β-thalassemia intermedia patients.
Lai Y; Zhou L; Yi S; Chen Y; Tang Y; Yi S; Yang Z; Wei H; Zheng C; He S
Blood Cells Mol Dis; 2017 Mar; 63():52-57. PubMed ID: 28160732
[TBL] [Abstract][Full Text] [Related]
17. [Molecular-genetic characteristics of alpha, beta and delta beta-thalassemias in 139 heterozygotes in 56 unrelated Czech and Slovak families (Priority description of 3 beta-thalassemia mutations, an extensive alpha-thalassemia 2 (18+ kb) deletion and a Swiss-type nondeletion hereditary persistence of hemoglobin F)].
Indrák K; Divoký V; Brabec V; Indráková J; Svobodová M; Huisman TH
Vnitr Lek; 1993 Oct; 39(10):969-78. PubMed ID: 7694425
[TBL] [Abstract][Full Text] [Related]
18. The association of HBG2, BCL11A, and HBS1L-MYB polymorphisms to thalidomide response in Chinese β-thalassemia patients.
Yang K; Wu Y; Ma Y; Xiao J; Zhou Y; Yin X
Blood Cells Mol Dis; 2020 Sep; 84():102442. PubMed ID: 32387854
[TBL] [Abstract][Full Text] [Related]
19. β- and α-Thalassemia intermedia in Basra, Southern Iraq.
Abdulwahid DA; Hassan MK
Hemoglobin; 2013; 37(6):553-63. PubMed ID: 23944608
[TBL] [Abstract][Full Text] [Related]
20. New Insights on β-Thalassemia in the Palestinian Population of Gaza: High Frequency and Milder Phenotype Among Homozygous IVS-I-1 (HBB: c.92+1G>A) Patients with High Levels of Hb F.
Ghoti H; Fibach E; Rachmilewitz EA; Jeadi H; Filon D
Hemoglobin; 2017 Mar; 41(2):144-146. PubMed ID: 28670942
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
